We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
26
Visa
V
$677B
$14.8M 0.45%
42,203
-4,018
-9% -$1.37M
MA icon
27
Mastercard
MA
$477B
$14.7M 0.45%
25,823
+1,814
+8% +$1.01M
WMT icon
28
Walmart Inc
WMT
$871B
$14.7M 0.44%
131,725
+794
+0.6% +$85.3K
ASML icon
29
ASML
ASML
$675B
$14.3M 0.43%
13,401
+108
+0.8% +$113K
ORCL icon
30
Oracle
ORCL
$331B
$13.9M 0.42%
71,339
-479
-0.7% -$114K
XOM icon
31
ExxonMobil
XOM
$651B
$13.5M 0.41%
112,366
+9,987
+10% +$1.16M
BAC icon
32
Bank of America
BAC
$435B
$12.4M 0.37%
225,294
+2,792
+1% +$148K
ABBV icon
33
AbbVie
ABBV
$458B
$12.3M 0.37%
53,887
-460
-0.8% -$105K
NFLX icon
34
Netflix
NFLX
$292B
$12.2M 0.37%
129,635
+3,835
+3% +$413K
TGT icon
35
Target
TGT
$62.1B
$11.8M 0.36%
120,648
-6,941
-5% -$640K
AXP icon
36
American Express
AXP
$223B
$11.8M 0.36%
31,804
-1,332
-4% -$477K
HD icon
37
Home Depot
HD
$332B
$10.7M 0.32%
31,156
-7,859
-20% -$2.88M
VGSH icon
38
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$10.2M 0.31%
173,423
+30,556
+21% +$1.8M
COST icon
39
Costco
COST
$415B
$9.96M 0.3%
11,545
+740
+7% +$671K
CSCO icon
40
Cisco
CSCO
$450B
$9.78M 0.3%
126,899
+6,698
+6% +$497K
GE icon
41
GE Aerospace
GE
$367B
$9.66M 0.29%
31,348
+2,288
+8% +$689K
VV icon
42
Vanguard Large-Cap ETF
VV
$51.9B
$9.62M 0.29%
30,557
+2,400
+9% +$749K
MRK icon
43
Merck
MRK
$324B
$9.23M 0.28%
87,645
+991
+1% +$93K
AZN icon
44
AstraZeneca
AZN
$263B
$9.09M 0.27%
49,465
+2,324
+5% +$408K
UNH icon
45
UnitedHealth
UNH
$382B
$8.94M 0.27%
27,081
-724
-3% -$245K
PEP icon
46
PepsiCo
PEP
$186B
$8.88M 0.27%
61,891
-1,080
-2% -$159K
KO icon
47
Coca-Cola
KO
$354B
$8.8M 0.27%
125,869
+14,624
+13% +$1.02M
WFC icon
48
Wells Fargo
WFC
$261B
$8.7M 0.26%
93,361
+1,384
+2% +$120K
TMO icon
49
Thermo Fisher Scientific
TMO
$211B
$8.34M 0.25%
14,401
+124
+0.9% +$70.1K
NVS icon
50
Novartis
NVS
$295B
$8.25M 0.25%
59,860
+166
+0.3% +$21.7K

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.